We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
40 hedge funds and large institutions have $60.8M invested in Fate Therapeutics in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
154% more capital invested
Capital invested by funds: $23.9M → $60.8M (+$36.9M)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 39 → 40 (+1)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
8
Increased
10
Reduced
13
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$11.7M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.43M |
| 3 |
KCM
Kingdon Capital Management
New York
|
+$1.38M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.1K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$71.6K |
